Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2025 Earnings Call Transcript
Operator: Hello. Welcome to Vir Biotechnology's First Quarter 2025 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
Vir Biotechnology Inc. (VIR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 2,248,249 | $14,568,654 | -31% | 0.35% |
| 2. | Citadel Investment Group Ken Griffin | 1,617,228 | $10,479,638 | +497% | 0% |
| 3. | Renaissance Technologies Jim Simons | 1,120,400 | $7,260,192 | -10% | 0.01% |
| 4. | Ikarian Capital Neil Shahrestani | 1,068,062 | $6,921,041 | +19% | 0.85% |
| 5. | Catalio Capital Management George Petrocheilos And R. Jacob Vogelstein | 611,608 | $3,963,220 | 0.96% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.73 | 2,500 | Director | 10,000 | 2023-03-01 | Filing | |
| $24.96 | 2,500 | Director | 7,500 | 2023-01-05 | Filing | |
| $25.25 | 2,500 | Director | 5,000 | 2023-01-04 | Filing | |
| $25.60 | 2,500 | Director | 2,500 | 2023-01-03 | Filing | |
| $43.39 | 12 | Officer | 12 | 2021-11-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.95 | 79,712 | Officer, Director | 769,505 | 2025-04-03 | Filing | |
| $9.14 | 7,373 | Officer | 79,460 | 2025-02-26 | Filing | |
| $9.45 | 10,056 | Director | 698,239 | 2025-02-24 | Filing | |
| $9.45 | 14,168 | Officer | 117,901 | 2025-02-24 | Filing | |
| $9.45 | 1,562 | Officer | 46,627 | 2025-02-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,684,041 | $108,112,586 | 0.99% | |
| 2. | 16,541,330 | $107,187,817 | 0% | |
| 3. | 12,807,508 | $82,992,651 | 0% | |
| 4. | 5,727,163 | $37,112,016 | 0% | |
| 5. | 2,684,415 | $17,396,913 | 0% |
News See All
10 Stocks Under $10 that Will Triple
As we delve into the discussion on stocks that will triple, we must shed light on the U.S.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2024 Earnings Call Transcript
Operator: Hello. Welcome to Vir Biotechnology’s Fourth Quarter and Full Year 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
Why These 15 Stocks Are Skyrocketing in 2025
The market has started to favor smaller companies in 2025, and stocks between $1 billion and $5 billion in market value are attracting renewed interest.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2024 Earnings Call Transcript
Operator: [Call starts abruptly] …Vir's Third Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q2 2024 Earnings Call Transcript
Operator: Hello. Welcome to Vir Biotechnology’s Second Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript
Operator: Hello. Welcome to Vir Biotechnology’s First Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript
Vir Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.86, expectations were $-1.14. Vir Biotechnology, Inc.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to Vir Biotechnology's Third Quarter 2023 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
10 Oversold Healthcare Stocks to Buy
In this article, we will take a look at the 10 healthcare stocks to buy.
Billionaire Hedge Funds
